Skip to main content

Table 2 Tumor response after radiotherapy

From: Trimodality bladder-sparing approach without neoadjuvant chemotherapy for node-negative localized muscle-invasive urinary bladder cancer resulted in comparable cystectomy-free survival

  Evaluable patients (n = 64)
Complete response (CR) 50 (78.1%)
Partial response (PR) 2 (3.1%)
Stable disease (SD) 3 (4.7%)
Progressive disease (PD) 9 (14.1%)